There are currently 7 active clinical trials seeking participants for Presbyopia research studies. The states with the highest number of trials for Autism participants are California, Florida, Texas and Tennessee.
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
NCT06053463
Recruiting
To explore the wear experience in Dailies TOTAL1 Multifocal contact lenses in presbyopic adults who have previously dropped out of contact lens wear.
Gender:
All
Ages:
38 years and above
Trial Updated:
04/01/2024
Locations: The Ohio State University College of Optometry, Columbus, Ohio +1 locations
Conditions: Presbyopia
Register for Updates
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
NCT05135286
Recruiting
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Gender:
All
Ages:
Between 45 years and 80 years
Trial Updated:
04/22/2024
Locations: Visus Therapeutics Investigative Site, Chandler, Arizona +42 locations
Conditions: Presbyopia
Register for Updates
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
NCT06232590
Recruiting
To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
Gender:
All
Ages:
42 years and above
Trial Updated:
04/02/2024
Locations: Complete Eye Care of Medina, Medina, Minnesota +4 locations
Conditions: Presbyopia
Register for Updates
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
NCT05796453
Recruiting
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/18/2024
Locations: Wolstan & Goldberg Eye Associates, Torrance, California +6 locations
Conditions: Aphakia, Astigmatism, Presbyopia
Register for Updates
IC-8 Apthera IOL New Enrollment Post Approval Study
NCT06060041
Recruiting
The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.
Gender:
All
Ages:
22 years and above
Trial Updated:
11/28/2023
Locations: Trinity Research Group, LLC, Dothan, Alabama +11 locations
Conditions: Cataract, Presbyopia, Posterior Capsule Opacification
Register for Updates
Clinical Applications of Advanced Ophthalmic Imaging
NCT03135327
Recruiting
The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medica... Read More
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
09/12/2023
Locations: Bascom Palmer Eye Institute, Miami, Florida
Conditions: Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy, Presbyopia, Myopia, Dementia
Register for Updates
Extended Depth of Focus Contact Lenses for Presbyopia
NCT05495971
Recruiting
VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.
Gender:
All
Ages:
Between 45 years and 70 years
Trial Updated:
10/03/2022
Locations: VTI, Alpharetta, Georgia
Conditions: Presbyopia
Register for Updates